Category: Cancer detection
-
In Memoriam: Professor Greg Hannon (1964–2026)
It is with profound sadness that we share the news of the passing of Professor Greg Hannon, who led the Cancer Research UK Cambridge Institute for over eight years.
Find out more -
Most detailed map of breast tissue changes reveals role of menopause in cancer susceptibility
Scientists have created the most detailed map to date, comprising over 3 million cells, showing how breast tissue changes as women age – including dramatic changes during menopause.
-
Hannon Group joins global team to decode cancer’s dark proteome
Prof Greg Hannon and his group joins global Cancer Grand Challenges team taking on the dark proteome challenge.Â
Find out more -
1M to advance AI powered personalised ovarian cancer care
Researchers from our Brenton Group are part of an international team awarded the Global Ovarian Cancer Research Consortium’s inaugural AI Accelerator Grant.
Find out more -
Professor Sir Steve Jackson elected as a fellow of the American Association for Cancer Research
Senior Group Leader Sir Steve Jackson has been elected as a Fellow of the American Association for Cancer Research Academy in the Class of 2026.
Find out more -
New immune pathway offers treatment hope for childhood brain tumours
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more -
Targeting paused cells could improve chemotherapy for lung and ovarian cancers
New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented.
Find out more -
Hot flush treatment has anti-breast cancer activity, study finds
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Find out more -
Dr Richard Mair to co-lead ÂŁ13.7M investment for brain tumour research
The National Institute for Health and Care Research (NIHR) has today announced a ÂŁ13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
Find out more